Essity B, SE0009922164

Essity stock faces PFAS lawsuit over Carefree liners

Published on 11/04/2026 at 18:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Essity faces a California lawsuit over alleged PFOA in Carefree liners. The company rejects intentional PFAS use and plans a vigorous response.

Legal scrutiny meets a higher quote

  • Hundreds of California residents accuse Essity and other companies of selling Carefree liners allegedly made with PFOA.
  • Essity rejects intentional PFAS use and plans to respond vigorously to the claims.
  • The lawsuit adds compliance and potential litigation-cost risk to Essity's recently expanded feminine-care business.
Essity B, SE0009922164, Illustration mit AI erstellt.

Essity faces fresh legal scrutiny after hundreds of California residents sued over Carefree panty liners allegedly containing perfluorooctanoic acid, or PFOA. The complaint was filed on October 9, 2026, in the Superior Court of Los Angeles County, according to Manufacturing Dive.

Allegations target Carefree products

The plaintiffs accuse Essity, Edgewell and Johnson & Johnson of manufacturing and distributing Carefree products intentionally made with PFOA. Gelson's Markets is also named over the alleged sale of the products. The claims concern California restrictions on menstrual products intentionally made with PFAS that took effect on January 1, 2025.

The lawsuit cites an independent laboratory test from 2024 that allegedly found PFOA in one or more of five Carefree product layers. The plaintiffs seek compensation for alleged physical and emotional harm, medical expenses and related injuries. The allegations have not been established by a court.

Essity rejects intentional PFAS use

Essity spokesperson Amy Bellcourt said Carefree stands behind its products. She said the company does not intentionally add PFAS chemicals, that PFAS are not ingredients used to make the products and that the ingredients are printed on the packaging. Essity plans to respond vigorously to the claims.

Essity acquired Edgewell's North American feminine-care business on February 4, 2026, bringing Carefree into its portfolio. The lawsuit therefore puts product compliance, reputation and potential litigation costs in focus as the business is integrated, although the filing itself does not establish financial liability.

Quote and investor context

Essity stock traded at 26.30 euros on Lang & Schwarz at 18:03 CET on Wednesday, November 4, 2026. The real-time quote of Essity stock provides the latest market reference.

Essity B investor facts

  • Company: Essity AB (publ)
  • ISIN: SE0009922164
  • Ticker: ESSITY-B.ST
  • Primary exchange: Nasdaq Stockholm
  • Lang & Schwarz quote: 26.30 euros on Wednesday, November 4, 2026 at 18:03 CET
  • Sector: Consumer Defensive
  • Industry: Household and Personal Products

The OMXS30 offers the broader Swedish equity-market context for Essity investors.

More news and analyses on Essity stock.

Disclaimer...
en | SE0009922164 | ESSITY B | boerse | 70458569 |